Menopause and perimenopause treatment plans

Search documents
Hims & Hers (HIMS) Soars 16% as Firm On Track to Book $1 Billion Revenues from Women Segment
Yahoo Finance· 2025-10-16 14:31
We recently published 10 Stocks Stealing Today’s Spotlight; 5 on All-Time Highs. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best performers on Wednesday. Hims & Hers soared by 16.18 percent on Wednesday to end at $62.76 apiece as investors cheered the company’s optimism that it would surpass its $1 billion revenue target from women’s health alone in 2026. This followed the official launch of new menopause and perimenopause treatment plans tailored to women’s health history and personal preference ...